Veness Adam M
CIK: 0001778623•SVP, General Counsel and Sec.
Officer
Primary company: ACCELERON PHARMA INC (XLRN)
Veness Adam M is a corporate insider (SVP, General Counsel and Sec.) at ACCELERON PHARMA INC (XLRN) filing SEC Form 4 transactions. 54 transactions across 3 companies, totaling $0 in purchases and $2,399,981 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 16,167 | $17.88 | $289K | 60,000 | 8/10/2026 Filed: 8/7/2026 | Filing → | |
| Sale | 16,167 | $110.38 | $1.78M | 0 | 8/10/2026 Filed: 8/7/2026 | Filing → | |
| Exercise | 16,167 | $17.88 | $289K | 16,167 | 8/10/2026 Filed: 8/7/2026 | Filing → | |
| Exercise | 3,833 | $17.88 | $69K | 76,167 | 8/7/2026 Filed: 8/7/2026 | Filing → | |
| Sale | 616 | $111.18 | $68K | 0 | 8/7/2026 Filed: 8/7/2026 | Filing → | |
| Sale | 3,217 | $110.61 | $356K | 616 | 8/7/2026 Filed: 8/7/2026 | Filing → | |
| Exercise | 3,833 | $17.88 | $69K | 3,833 | 8/7/2026 Filed: 8/7/2026 | Filing → | |
| Award | 100,000 | $22.07 | $2.21M | 100,000 | 2/3/2025 Filed: 2/4/2025 | Filing → | |
| Award | 75,000 | - | - | 75,000 | 5/23/2024 Filed: 5/28/2024 | Filing → | |
| Award | 110,000 | - | - | 110,000 | 1/24/2024 Filed: 1/26/2024 | Filing → | |
Cyteir Therapeutics, Inc. CYT | Award | 96,100 | $0.00 | $0 | 96,100 | 2/3/2023 Filed: 2/7/2023 | Filing → |
Cyteir Therapeutics, Inc. CYT | Award | 177,000 | $0.00 | $0 | 177,000 | 5/2/2022 Filed: 5/4/2022 | Filing → |
| Disposition | 18,806 | - | - | 0 | 11/19/2021 Filed: 11/22/2021 | Filing → | |
| Disposition | 24,334 | - | - | 0 | 11/19/2021 Filed: 11/22/2021 | Filing → | |
| Disposition | 8,500 | - | - | 0 | 11/19/2021 Filed: 11/22/2021 | Filing → | |
| Disposition | 7,650 | - | - | 0 | 11/19/2021 Filed: 11/22/2021 | Filing → | |
| Disposition | 6,700 | - | - | 0 | 11/19/2021 Filed: 11/22/2021 | Filing → | |
| U | 23,423 | - | - | 0 | 11/19/2021 Filed: 11/22/2021 | Filing → | |
| Exercise | 4,500 | $0.00 | $0 | 0 | 11/9/2021 Filed: 11/12/2021 | Filing → | |
| Exercise | 4,500 | $29.37 | $132K | 23,423 | 11/9/2021 Filed: 11/12/2021 | Filing → |
Type
Exercise
Shares
16,167
Price
$17.88
Value
$289K
Type
Sale
Shares
16,167
Price
$110.38
Value
$1.78M
Type
Exercise
Shares
16,167
Price
$17.88
Value
$289K
Type
Exercise
Shares
3,833
Price
$17.88
Value
$69K
Type
Sale
Shares
616
Price
$111.18
Value
$68K
Type
Sale
Shares
3,217
Price
$110.61
Value
$356K
Type
Exercise
Shares
3,833
Price
$17.88
Value
$69K
Type
Award
Shares
100,000
Price
$22.07
Value
$2.21M
Type
Award
Shares
75,000
Price
-
Value
-
Type
Award
Shares
110,000
Price
-
Value
-
Cyteir Therapeutics, Inc.
CYT
Type
Award
Shares
96,100
Price
$0.00
Value
$0
Cyteir Therapeutics, Inc.
CYT
Type
Award
Shares
177,000
Price
$0.00
Value
$0
Type
Disposition
Shares
18,806
Price
-
Value
-
Type
Disposition
Shares
24,334
Price
-
Value
-
Type
Disposition
Shares
8,500
Price
-
Value
-
Type
Disposition
Shares
7,650
Price
-
Value
-
Type
Disposition
Shares
6,700
Price
-
Value
-
Type
U
Shares
23,423
Price
-
Value
-
Type
Exercise
Shares
4,500
Price
$0.00
Value
$0
Type
Exercise
Shares
4,500
Price
$29.37
Value
$132K
AI Agent
Try asking...